Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2014, 15(4), 5522-5535; doi:10.3390/ijms15045522
Article

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass

1,* , 2
, 1
, 1
 and 1
Received: 17 February 2014; in revised form: 18 March 2014 / Accepted: 24 March 2014 / Published: 31 March 2014
(This article belongs to the Special Issue ADMA and Nitrergic System)
View Full-Text   |   Download PDF [551 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: The purpose of the work was to study the impact of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH1), on atherosclerosis in subtotally nephrectomized (SNX) ApoE-deficient mice. Male DDAH1 transgenic mice (TG, n = 39) and C57Bl/6J wild-type littermates (WT, n = 27) with or without the deletion of the ApoE gene underwent SNX at the age of eight weeks. Animals were sacrificed at 12 months of age, and blood chemistry, as well as the extent of atherosclerosis within the entire aorta were analyzed. Sham treated (no renal mass reduction) ApoE-competent DDAH1 transgenic and wild-type littermates (n = 11) served as a control group. Overexpression of DDAH1 was associated with significantly lower ADMA levels in all treatment groups. Surprisingly, SNX mice did not exhibit higher ADMA levels compared to sham treated control mice. Furthermore, the degree of atherosclerosis in ApoE-deficient mice with SNX was similar in mice with or without overexpression of DDAH1. Overexpression of the ADMA degrading enzyme, DDAH1, did not ameliorate atherosclerosis in ApoE-deficient SNX mice. Furthermore, SNX in mice had no impact on ADMA levels, suggesting a minor role of this molecule in chronic kidney disease (CKD) in this mouse model.
Keywords: ADMA; subtotal nephrectomy; atherosclerosis ADMA; subtotal nephrectomy; atherosclerosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Jacobi, J.; Maas, R.; Arend, M.; Cordasic, N.; Hilgers, K.F. Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass. Int. J. Mol. Sci. 2014, 15, 5522-5535.

AMA Style

Jacobi J, Maas R, Arend M, Cordasic N, Hilgers KF. Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass. International Journal of Molecular Sciences. 2014; 15(4):5522-5535.

Chicago/Turabian Style

Jacobi, Johannes; Maas, Renke; Arend, Michaela; Cordasic, Nada; Hilgers, Karl F. 2014. "Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass." Int. J. Mol. Sci. 15, no. 4: 5522-5535.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert